Managing Patients with Recent Worsening Heart Failure with Reduced Ejection Fraction:
Keys to Successful Outcomes

Dinner and Registration: 6:00PM - 6:30PM CT
Symposium: 6:30PM - 8:00PM CT

Venue: Marriot Marquis Chicago
Ballroom: Great Lakes FG
2121 South Prarie Avenue, Chicago, Illinois

Chair: John Teerlink, MD

Faculty: Nancy Albert, PhD, RN; Barry Greenberg, MD; Scott Solomon, MD; Jane Wilcox, MD, MSc

Registration for this program is now closed.

Patients with heart failure with reduced ejection fraction (HFrEF) and recent worsening heart failure (WHF) have high rates of death and hospitalization despite the use of guideline-directed medical therapy (GDMT). Moreover, the administration of GDMT and the achievement of target doses are often difficult in these patients. Therefore, patients with HFrEF and recent WHF events are at significantly increased risk, underscoring the need for new therapies for this large subgroup of patients with HFrEF. New and emerging novel agents, with distinct mechanisms of action, have demonstrated improved clinical outcomes in these patients, and clinicians must be able to not only identify appropriate patients for these therapies--personalizing treatment based on the patient’s profile--but also utilize these therapies effectively in practice. Regardless of whether HF therapies are initiated in or out of the hospital, patient education and self-care are critical components of overall patient management. Preventive strategies such as risk factor control, treatment of comorbidities, and emphasis on adherence to the medication regimen are essential. Hospitalized patients with WHF require well-developed and executed transitions of care to prevent re- hospitalization and facilitate improved patient outcomes. Therefore, in this program, HF experts will explain the challenges in managing patients with HFrEF and recent WHF, identify the roles for new and emerging therapies, and describe best practices to prevent adverse HF-related events.

Educational Objectives: 

1. Describe the characteristics of, and outcomes associated with patients with recent worsening heart failure (WHF) and reduced ejection fraction
2. Interpret the evidence from clinical studies of new and emerging therapies in patients with heart failure with reduced ejection fraction (HFrEF) who have experienced a recent WHF event
3. Indicate key elements of effective transitions of care for patients with heart failure
4. Recognize the complexity of implementation and up-titration of guideline- directed medical therapy (GDMT) in patients with HFrEF and the need to personalize treatment
5. Discuss best practices for tailoring additional medical therapies to patients with HFrEF

Accreditation & Credit Designation:
Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits^TM through its reciprocity agreements.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits ^TM from organizations accredited by the ACCME.

Educational Grant:Voxmedia International gratefully acknowledges the independent educational grant provided by Cytokinetics Incorporated.

Target Audience:  This educational activity is intended for clinicians who manage patients with heart failure.